TAO Synergies

New York, United States

TAO Synergies is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.

$11.0M raised

Oct 2025

Post-IPO Equity

Biopharma Biotechnology Pharmaceutical

Top Investors

Bantam Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TAO Synergies

How much funding has TAO Synergies raised?

TAO Synergies has raised $11.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.

Who are TAO Synergies's investors?

TAO Synergies's investors include Bantam Group.

Where is TAO Synergies headquartered?

TAO Synergies is headquartered in New York, United States.

What does TAO Synergies do?

TAO Synergies is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.

What stage is TAO Synergies at?

TAO Synergies is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 13, 2025.

MLA

"TAO Synergies — Funding & Investors." VCBacked, October 13, 2025, https://www.vcbacked.co/company/tao-synergies. Accessed July 5, 2026.

APA

VCBacked. (2025). TAO Synergies — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/tao-synergies

Wikipedia (cite web)

{{cite web |title=TAO Synergies — Funding & Investors |url=https://www.vcbacked.co/company/tao-synergies |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 13, 2025.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.